Home Enoxaparin induced reactive thrombocytosis: a rare adverse drug reaction
Article
Licensed
Unlicensed Requires Authentication

Enoxaparin induced reactive thrombocytosis: a rare adverse drug reaction

  • Saleel Salman Meenpidiyil EMAIL logo , Shihas Azeez , Vaisakh Prasanna Kumar , Dhanush Suresh , Sareena Kalathathoduuill , Safa Thandupara and Muhammed Hashik Puthukudi
Published/Copyright: June 24, 2020

Abstract

Objectives

Enoxaparin is a low molecular weight heparin (LMWH), which belongs to the class of anticoagulants. The drug is administered as subcutaneous injection to prevent or treat deep vein thrombosis (DVT), pulmonary embolism and ischemic complications.

Case Presentation

A 57-year-old women diagnosed with acute coronary syndrome developed reactive thrombocytosis following the administration of enoxaparin subcutaneously. The blood test reports of the patient showed that there is a gradual elevation of platelet count day by day following enoxaparin administration. On an assessment using both World Health Organization–Uppsala Monitoring Centre (WHO–UMC) scale and Naranjo Causality Assessment Scale indicated that enoxaparin is the “probable” cause for the reaction.

Conclusions

We conclude that reactive thrombocytosis is a probable adverse drug reaction and close monitoring of blood counts is essential, following enoxaparin injection. More studies are to be conducted to identify further complications.


Corresponding author: Saleel Salman Meenpidiyil, Department of Pharmacy Practice, Al Shifa College of Pharmacy, Perinthalmanna, Malappuram, 679325, Kerala, India, Ph: +91 7558966284, E-mail:

Acknowledgments

The authors wish to express their deep gratitude to the entire dignitaries, who have been supportive in the successful completion of this work.

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The ethical approval was deemed by the hospital ethics committee.

References

1. Tripathi, KD. Essentials of medical pharmacology, 7th ed. New Delhi: Jaypee Brothers Medical Publishers; 2013:619.10.5005/jp/books/12256Search in Google Scholar

2. Lepercq, J, Conard, J, Borel-Derlon, A, Darmon, JY, Boudignet, O, Francoual, C, et al. Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies. An Int J Obstet Gynaecol 2001;108:1134140. https://doi.org/10.1111/j.1471-0528.2003.00272.x.Search in Google Scholar PubMed

3. Aydogan, T, Kanbay, M, Alici, O, Kosar, A. Incidence and etiology of thrombocytosis in an adult Turkish population. Platelets 2006;17:328–31. https://doi.org/10.1080/09537100600746573.Search in Google Scholar PubMed

4. Araneda, M, Krishnan, V, Hall, K, Kalbfleisch, J, Krishnaswamy, G, Krishnan, K. Reactive and clonal thrombocytosis: pro-inflammatory and hematopoietic cytokines and acute phase proteins. Southern medical journal 2001;94:417–20.10.1097/00007611-200194040-00012Search in Google Scholar

5. Santhosh-Kumar, CR, Yohannan, MD, Higgy, KE, Al-Mashhadani, SA. Thrombocytosis in adults: analysis of 777 patients. J Int Med 1991;229:493–5. https://doi.org/10.1111/j.1365-2796.1991.tb00383.Search in Google Scholar

6. Vo, QT, Thompson, DF. A review and assessment of drug induced thrombocytosis. Ann Pharmacother 2019;53:523–36. https://doi.org/10.1177/1060028018819450.Search in Google Scholar PubMed

7. Frye, JL, Thompson, DF. Drug-induced thrombocytosis. J Clin Pharm Ther 1993;18:45–8.10.1111/j.1365-2710.1993.tb00565.xSearch in Google Scholar PubMed

8. Hummel, MC, Morse, BC, Hayes, LE. Reactive thrombocytosis associated with enoxaparin. Pharmacotherapy 2006;26:1667–70. https://doi.org/10.1592/phco.26.11.1667.Search in Google Scholar PubMed

Received: 2019-10-19
Accepted: 2020-03-16
Published Online: 2020-06-24

© 2020 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 23.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jbcpp-2019-0312/html?lang=en
Scroll to top button